Common skin infections in children

British Medical Journal

Volumn 329, Issue 7457, 2004, Pages 95-99

  Sladden, Michael J ^a   Johnston, Graham A ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFALEXIN; FLUCLOXACILLIN; FUSIDIC ACID; GRISEOFULVIN; IMIQUIMOD; NITRITE; PENICILLIN G; PHENOL; PSEUDOMONIC ACID; SALICYLIC ACID;

ALLERGY; CLINICAL FEATURE; CLINICAL TRIAL; COCHRANE LIBRARY; CRYOTHERAPY; GASTROINTESTINAL TOXICITY; HUMAN; IMPETIGO; MOLLUSCUM CONTAGIOSUM; NAUSEA; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RASH; REVIEW; SCAR FORMATION; SKIN INFECTION; SKIN IRRITATION; TINEA CAPITIS; VERRUCA VULGARIS;

EID: 3142556105     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.329.7457.95     Document Type: Review

References (28)

1. Hayden GF. Skin diseases encountered in a pediatric clinic. A one-year prospective study. Am J Dis Childhood 1985;139:36-8.
2. Tunnessen WW. A survey of skin disorders seen in pediatric general and dermatology clinics. Pediatr Dermatol 1984;1:219-22.
3. Findlay GH, Vismer HF, Sophianos T. The spectrum of pediatric dermatology. Analysis 10,000 cases. Br J Dermatol 1974;91:379-87.
4. Rogers M, Barnetson RSC. Diseases of the skin. In: Campbell AGM, McIntosh N, eds. Forfar and Arneil's textbook of pediatrics. 5th ed. New York: Churchill Livingstone, 1998:1633-5.
5. Koning S, Bruijnzeels MA, van Suijlekom-Smit LWA, van der Wouden JC. Molluscum contagiosum in Dutch general practice. Br J Gen Pract 1994;44:417-9.
6. Weller R, O'Callaghan CJ, MacSween RM, White MI. Scarring in molluscum contagiosum: comparison of physical expression and phenol ablation. BMJ 1999;319:1540.
7. Van der Wouden JC, Gajadin S, Berger MY, Butler CC, Koning S, Menke J, et al. Interventions for molluscum contagiosum in children. Cochrane Library: 2004, Issue 2. Chichester: Wiley.
8. Ormerod AD, White MI, Shah SA, Benjamin N. Molluscum contagiosum effectively treated with a topical acidified nitrite, nitric oxide liberating cream. Br J Dermatol 1999;141;1051-3.
9. Bayerl C, Feller G, Goerdt S. Experience in treating molluscum contagiosum in children with imiquimod 5% cream. Br J Dermatol 2003;149(suppl):25-9.
10. Sterling JC, Kurtz JB. Viral infections. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Rook textbook of dermatology. 6th ed Oxford: Blackwell, 1998.
11. Gibbs S, Harvey I, Sterling JC, Stark R. Local treatments for cutaneous warts. Cochrane Database Syst Rev 2003;(3):CD001781.
12. Williams HC, Pottier A, Strachan D. The descriptive epidemiology of warts in British schoolchildren. Br J Dermatol 1993;128:504-11.
13. Gibbs S, Harvey I, Sterling J, Stark R. Local treatments for cutaneous warts: systematic review BMJ 2002;325:461.
14. Resnick S. Staphylococcal and streptococcal skin infections: pyodermas and toxin-mediated syndromes. In: Harper JO, A. Prose N, eds. Textbook of pediatric dermatology. Oxford: Blackwell, 2000:369-77.
15. Dagan R. Impetigo in childhood: changing epidemiology and new treatments. Ped Annals 1993;22:235-40.
16. Bruijnzeels MA, van Suijlekom-Smit LWA, van der Velden J, van der Wouden JC. The child in general practice. Dutch national survey of morbidity and interventions in general practice. Rotterdam: Erasmus University Rotterdam, 1993.
17. Hlady WG, Middaugh JP. An epidemic of bullous impetigo in a newborn nursery due to Staphylococcus aureus: epidemiology and control measures. Alaska Med 1986;28:99-103.
18. Koning S, Verhagen AP, van Suijlekom-Smit LWA, Morris A, Butler CC, van der Wouden JC. Interventions for impetigo. Cochrane Database Syst Rev 2004;2:CD003261.
19. Feingold DS. Staphylococcal and streptococcal pyodermas. Semin Dermatol 1993;12:331-5.
20. González U, Seaton T, Bergus G, Torres JM, Jacobson J. Systemic antifungal therapy for tinea capitis in children. Cochrane Library, 2004: Issue 2. Chichester: Wiley.
21. Aly R. Ecology and epidemiology of dermatophyte infections. J Am Acad Dermatol 1994;31:S21-5.
22. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. Br J Dermatol 2000;143:53-8.
23. Bronson DM, Desai DR, Barskey S. An epidemic of infection with Trichophyton tonsurans revealed in a twenty year survey of fungal pathogens in Chicago. J Am Acad Dermatol 1983;8:322-30.
24. Fuller LC, Child FJ, Midgley G, Higgins EM. Diagnosis and management of scalp ringworm. BMJ 2003;326:539-41.
25. Fuller LC, Child FC, Midgley G, Higgins EM. Scalp ringworm in south-east London and an analysis of a cohort of patients from a paediatric dermatology department. Br J Dermatol 2003;148:985-8.
26. Caceres-Rios H, Rueda M, Ballona R, Bustamante B. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. J Am Acad Dermatol 2000;42:80-4.
27. Fuller LC, Smith CH, Cerio R, Marsden RA, Midgley G, Beard AL, et al. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Br J Dermatol 2001;144:321-7.
28. Gupta AK, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol 2001;18:433-8.